U.S. Treasury Publishes General License 129 for Rosneft Entities Under Russia Sanctions

Estimated reading time: 3–5 minutes

The U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC) has published General License No. 129 (GL 129) related to the Russian Harmful Foreign Activities Sanctions Regulations.

GL 129 was originally issued on October 29, 2025. It appeared on OFAC’s official website the same day. It is now published in the Federal Register, Volume 91, Number 12, on pages 2301–2302.

This license allows some transactions involving two specific companies: Rosneft Deutschland GmbH (also called RN Germany) and RN Refining & Marketing GmbH.

OFAC confirms that these transactions, which may otherwise be banned under the sanctions, can legally continue.

The license applies to transactions involving:

  • RN Germany and RN Refining & Marketing;
  • Any company where either RN Germany or RN Refining & Marketing owns 50% or more, directly or indirectly.

These authorized transactions are allowed through 12:01 a.m. Eastern Daylight Time on April 29, 2026.

However, some actions are still not allowed.

GL 129 does not permit:

  • Any transaction that is still banned under the Russian Harmful Foreign Activities Sanctions Regulations (31 CFR part 587);
  • Any transaction involving other blocked persons linked to the Rosneft Oil Company, unless another license allows it.

This general license is part of OFAC’s regulatory tools to enforce U.S. sanctions in a targeted and controlled manner.

The license was signed by Bradley T. Smith, the Director of OFAC, on October 29, 2025.

For more information, visit the OFAC website at https://ofac.treasury.gov or contact OFAC at 202-622-4855.

Reference: Federal Register Document Number 2026-00947.


Legal Disclaimer

This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.